The association between CTLA-4 (+49 A/G) polymorphism and susceptibility to ankylosing spondylitis: a meta-analysis

International Journal of Rheumatic Diseases

Volumn 19, Issue 12, 2016, Pages 1237-1243

  Wu, Jian ^a   Zhang, Liang ^a   Zhou, Yixin ^a  

^a Beijing Jishuitan Hospital   (China)

Author keywords

ankylosing spondylitis; CTLA 4; meta analysis; polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CTLA4 PROTEIN, HUMAN;

ANKYLOSING SPONDYLITIS; ARTICLE; EUROPEAN; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IRANIAN PEOPLE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWANESE; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; IMMUNOLOGY; IRAN; MALE; META ANALYSIS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; RISK FACTOR; SPONDYLITIS, ANKYLOSING; TAIWAN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CTLA-4 ANTIGEN; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRAN; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SPONDYLITIS, ANKYLOSING; TAIWAN; YOUNG ADULT;

EID: 85016830728     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12705     Document Type: Article

References (31)

1. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369, 1379–90.
2. Jacobs WB, Fehlings MG (2008) Ankylosing spondylitis and spinal cord injury: origin, incidence, management, and avoidance. Neurosurg Focus 24, E12.
3. Kouki T, Sawai Y, Gardine CA, Fisfalen M-E, Alegre M-L, Degroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165, 6606–11.
4. Scalapino KJ, Daikh DI (2008) CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev 223, 143–55.
5. Wulfing C, Tunbridge HM, Wraith DC (2014) New inhibitory signaling by CTLA-4. Nat Immunol 15, 408–9.
6. Minhas S, Bhalla S, Shokeen Y et al. (2014) Lack of any Association of the CTLA-4 + 49 G/A Polymorphism with Breast Cancer Risk in a North Indian Population. Asian Pac J Cancer Prev 15, 2035.
7. Ligers A, Teleshova N, Masterman T, Huang W, Hillert J (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2, 145–52.
8. Saraiva A, Donzele J, Oliveira R et al. (2012) Phosphorus requirements for 60-to 100-kg pigs selected for high lean deposition under different thermal environments. J Anim Sci 90, 1499–505.
9. Valk E, Rudd CE, Schneider H (2008) CTLA-4 trafficking and surface expression. Trends Immunol 29, 272–9.
10. Ueda H, Howson JM, Esposito L et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506–11.
11. Huang C-H, Wei JC-C, Chen C-C et al. (2014) Associations of the PTPN22 and CTLA-4 genetic polymorphisms with Taiwanese ankylosing spondylitis. Rheumatol Int 34, 683–91.
12. Lee WY, Chang YH, Lo MK et al. (2010) Polymorphisms of cytotoxic T lymphocyte-associated antigen-4 and cytokine genes in Taiwanese patients with ankylosing spondylitis. Tissue Antigens 75, 119–26.
13. Azizi E, Massoud A, Amirzargar AA et al. (2010) Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis. J Clin Immunol 30, 268–71.
14. Martin TM, Bye L, Modi N et al. (2009) Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Mol Vis 15, 208.
15. Soroosh SOG, Pasalar PA, Soroosh MO (2010) CTLA4 gene polymorphism in ankylosing spondylitis. Int J Rheum Dis 13, 4.
16. Clark MF, Baudouin SV (2006) A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 32, 1706–12.
17. Srivastava K, Srivastava A, Sharma KL, Mittal B (2011) Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res 728, 67–79.
18. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539–58.
19. Berg M, Zavazava N (2008) Regulation of CD28 expression on CD8 + T cells by CTLA-4. J Leukoc Biol 83, 853–63.
20. Marengère LE, Waterhouse P, Duncan GS, Mittrücker H-W, Feng G-S, Mak TW (1996) Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170–3.
21. Robinson PC, Brown MA (2012) The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheum Dis Clin North Am 38, 539–53.
22. Thomas GP, Brown MA (2010) Genetics and genomics of ankylosing spondylitis. Immunol Rev 233, 162–80.
23. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1, 904–7.
24. Zhang L, Liu J, Zhang Y, Wang H (2011) Association between HLA-B* 27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin Exp Rheumatol 29, 285.
25. Ma B, Yang B, Guo H et al. (2013) The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Hum Immunol 74, 1357–62.
26. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2005) Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 50, 453–9.
27. Galocha B, JAL DC (2008) Folding of HLA–B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum 58, 401–12.
28. Karaderi T, Harvey D, Farrar C et al. (2009) Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case–control study and meta-analysis of published series. Rheumatology 48, 386–9.
29. Duan Z, Pan F, Zeng Z et al. (2012) Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Int 32, 1209–14.
30. Chen R, Yao L, Meng T, Xu W (2012) The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls. Rheumatol Int 32, 909–14.
31. Lee YH, Choi SJ, Ji JD, Song GG (2011) Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res 60, 999–1003.